AstraZeneca PLC (AZN)
68.36
-0.17
(-0.25%)
USD |
NASDAQ |
Apr 18, 16:00
67.73
-0.63
(-0.92%)
After-Hours: 05:58
AstraZeneca Shares Outstanding: 3.100B for Jan. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
January 31, 2024 | 3.100B |
December 31, 2023 | 3.100B |
November 30, 2023 | 3.100B |
October 31, 2023 | 3.100B |
September 30, 2023 | 3.100B |
August 31, 2023 | 3.100B |
July 31, 2023 | 3.100B |
June 30, 2023 | 3.100B |
May 31, 2023 | 3.100B |
April 30, 2023 | 3.100B |
March 31, 2023 | 3.100B |
February 28, 2023 | 3.100B |
January 31, 2023 | 3.100B |
December 31, 2022 | 3.100B |
December 01, 2022 | 3.099B |
October 31, 2022 | 3.099B |
September 30, 2022 | 3.099B |
August 31, 2022 | 3.099B |
July 31, 2022 | 3.099B |
June 30, 2022 | 3.099B |
May 31, 2022 | 3.099B |
April 30, 2022 | 3.099B |
March 31, 2022 | 3.099B |
February 28, 2022 | 3.099B |
January 31, 2022 | 3.099B |
Date | Value |
---|---|
December 31, 2021 | 3.099B |
November 30, 2021 | 3.098B |
November 01, 2021 | 3.098B |
September 30, 2021 | 3.098B |
August 31, 2021 | 3.098B |
July 31, 2021 | 3.098B |
July 22, 2021 | 3.098B |
July 21, 2021 | 3.098B |
June 30, 2021 | 2.626B |
May 31, 2021 | 2.626B |
April 30, 2021 | 2.626B |
March 31, 2021 | 2.625B |
February 28, 2021 | 2.625B |
February 01, 2021 | 2.625B |
January 31, 2021 | 2.625B |
December 31, 2020 | 2.625B |
November 30, 2020 | 2.625B |
October 31, 2020 | 2.625B |
September 30, 2020 | 2.625B |
August 31, 2020 | 2.625B |
July 31, 2020 | 2.625B |
June 30, 2020 | 2.625B |
May 31, 2020 | 2.625B |
April 30, 2020 | 2.624B |
March 02, 2020 | 2.624B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
2.624B
Minimum
Apr 30 2019
3.100B
Maximum
Jan 31 2024
2.895B
Average
3.098B
Median
Shares Outstanding Benchmarks
GSK PLC | 2.043B |
Amgen Inc | 535.92M |
Gilead Sciences Inc | 1.246B |
Viking Therapeutics Inc | 100.49M |
Fusion Pharmaceuticals Inc | 84.69M |